News

Article

Rheumatoid Arthritis Quiz: RA and Employment

Author(s):

Lana Pine

Investigators evaluated employment rates at various disease stages of rheumatoid arthritis (RA) to uncover the key predictors influencing work among this patient population. Test your knowledge of employment and RA with this quiz.

What is the approximate prevalence of rheumatoid arthritis (RA) in the global population?


This content was generated with the assistance of artificial intelligence and edited for publication by the HCPLive editorial staff.

Related Videos
Jennifer Flemming, MD | Credit: AASLD
3 experts are featured in this series.
John Kane, MD | Credit: Northwell Health
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Related Content
Study Highlights New Data on Probiotics as Food Allergy Treatment for Children
January 17th 2025

Study Highlights New Data on Probiotics as Food Allergy Treatment for Children

Tim Smith
Default thumbnail for The Medical Sisterhood podcast
January 16th 2025

Medical Sisterhood: Polished and Powerful—Women Leading the Charge in Advocacy

Mona Shahriari, MD, FAAD Shadi Kourosh, MD, MPH
Marla Dubinsky, MD | Credit: The Sherman Prize
January 17th 2025

Marla Dubinsky, MD: Ushering In a New Era of Crohn’s Disease Treatment with Mirikizumab

Abigail Brooks, MA Marla Dubinsky, MD
Diabetes Dialogue: ADA’s 2025 Standards of Care in Diabetes | Image Credit: HCPLive
January 16th 2025

Diabetes Dialogue: ADA’s 2025 Standards of Care in Diabetes Technology

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
HHS Targets 15 Drugs for Medicare Part D Negotiations, Including Semaglutide | Image Credit: HHS
January 17th 2025

HHS Targets 15 Drugs for Medicare Part D Negotiations, Including Semaglutide

Connor Iapoce
Study Compares ChatGPT-4 Diagnostic Abilities to Teledermatologists
Published: January 17th 2025 | Updated: January 17th 2025

Study Compares ChatGPT-4 Diagnostic Abilities to Teledermatologists

Tim Smith
© 2025 MJH Life Sciences

All rights reserved.